Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Recombinant Vaccine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Recombinant Vaccine are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Recombinant Vaccine market segmented into
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines

Based on the end-use, the global Recombinant Vaccine market classified into
Human
Animal

Based on geography, the global Recombinant Vaccine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Merck & Co., Inc.
Green Cross Corporation
Pfizer, Inc.
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc
Novartis AG
Bharat Biotech

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RECOMBINANT VACCINE INDUSTRY
2.1 Summary about Recombinant Vaccine Industry
2.2 Recombinant Vaccine Market Trends
2.2.1 Recombinant Vaccine Production & Consumption Trends
2.2.2 Recombinant Vaccine Demand Structure Trends
2.3 Recombinant Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Subunit Recombinant Vaccines
4.2.2 Attenuated Recombinant Vaccines
4.2.3 Vector Recombinant Vaccines
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Human
4.3.2 Animal
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Subunit Recombinant Vaccines
5.2.2 Attenuated Recombinant Vaccines
5.2.3 Vector Recombinant Vaccines
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Human
5.3.2 Animal
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Subunit Recombinant Vaccines
6.2.2 Attenuated Recombinant Vaccines
6.2.3 Vector Recombinant Vaccines
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Human
6.3.2 Animal
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Subunit Recombinant Vaccines
7.2.2 Attenuated Recombinant Vaccines
7.2.3 Vector Recombinant Vaccines
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Human
7.3.2 Animal
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Subunit Recombinant Vaccines
8.2.2 Attenuated Recombinant Vaccines
8.2.3 Vector Recombinant Vaccines
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Human
8.3.2 Animal
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Subunit Recombinant Vaccines
9.2.2 Attenuated Recombinant Vaccines
9.2.3 Vector Recombinant Vaccines
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Human
9.3.2 Animal
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck & Co., Inc.
10.1.2 Green Cross Corporation
10.1.3 Pfizer, Inc.
10.1.4 Sanofi S A.
10.1.5 Protein Science Corporation
10.1.6 GlaxoSmithKline Plc
10.1.7 Novartis AG
10.1.8 Bharat Biotech
10.2 Recombinant Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 Merck & Co., Inc.
10.2.2 Green Cross Corporation
10.2.3 Pfizer, Inc.
10.2.4 Sanofi S A.
10.2.5 Protein Science Corporation
10.2.6 GlaxoSmithKline Plc
10.2.7 Novartis AG
10.2.8 Bharat Biotech
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
Table Recombinant Vaccine Product Type Overview
Table Recombinant Vaccine Product Type Market Share List
Table Recombinant Vaccine Product Type of Major Players
Table Brief Introduction of Merck & Co., Inc.
Table Brief Introduction of Green Cross Corporation
Table Brief Introduction of Pfizer, Inc.
Table Brief Introduction of Sanofi S A.
Table Brief Introduction of Protein Science Corporation
Table Brief Introduction of GlaxoSmithKline Plc
Table Brief Introduction of Novartis AG
Table Brief Introduction of Bharat Biotech
Table Products & Services of Merck & Co., Inc.
Table Products & Services of Green Cross Corporation
Table Products & Services of Pfizer, Inc.
Table Products & Services of Sanofi S A.
Table Products & Services of Protein Science Corporation
Table Products & Services of GlaxoSmithKline Plc
Table Products & Services of Novartis AG
Table Products & Services of Bharat Biotech
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Recombinant Vaccine Market Forecast (Million USD) by Region 2021f-2026f
Table Global Recombinant Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Recombinant Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Recombinant Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
Figure Global Recombinant Vaccine Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Recombinant Vaccine Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Recombinant Vaccine Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Recombinant Vaccine Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Recombinant Vaccine Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Recombinant Vaccine Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Recombinant Vaccine Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Subunit Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attenuated Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vector Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Animal Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Subunit Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attenuated Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vector Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Animal Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Subunit Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attenuated Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vector Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Animal Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Subunit Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attenuated Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vector Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Animal Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Subunit Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attenuated Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vector Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Animal Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Subunit Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attenuated Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vector Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Animal Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Vaccine Sales Revenue (Million USD) of Merck & Co., Inc. 2017-2020e
Figure Recombinant Vaccine Sales Revenue (Million USD) of Green Cross Corporation 2017-2020e
Figure Recombinant Vaccine Sales Revenue (Million USD) of Pfizer, Inc. 2017-2020e
Figure Recombinant Vaccine Sales Revenue (Million USD) of Sanofi S A. 2017-2020e
Figure Recombinant Vaccine Sales Revenue (Million USD) of Protein Science Corporation 2017-2020e
Figure Recombinant Vaccine Sales Revenue (Million USD) of GlaxoSmithKline Plc 2017-2020e
Figure Recombinant Vaccine Sales Revenue (Million USD) of Novartis AG 2017-2020e
Figure Recombinant Vaccine Sales Revenue (Million USD) of Bharat Biotech 2017-2020e

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, Deep Freezers & Reefer Containers, Cold Boxes & Vaccine Carriers, Cold Rooms/ Chillers, Other Equipment Types), By Purpose, By End-use, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...

Asia Pacific Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...

Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...

North America Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...

Global Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Region: Trend Forecast and Growth Opportunity...

Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...

Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Vaccine Supply Chain Solutions Market: The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...

Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Vaccine Tracking System Market: The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...